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Optical Mapping of Impulse Propagation
in Engineered Cardiac Tissue
Milica Radisic, Ph.D.,1 Vladimir G. Fast, Ph.D.,2 Oleg F. Sharifov, Ph.D.,2 Rohin K. Iyer, B.A.Sc.,1
Hyoungshin Park, Ph.D.,3,4 and Gordana Vunjak-Novakovic, Ph.D.5
Cardiac tissue engineering has a potential to provide functional, synchronously contractile tissue constructs for
heart repair, and for studies of development and disease using in vivo–like yet controllable in vitro settings. In both
cases, the utilization of bioreactors capable of providing biomimetic culture environments is instrumental for
supporting cell differentiation and functional assembly. In the present study, neonatal rat heart cells were
cultured on highly porous collagen scaffolds in bioreactors with electrical field stimulation. A hallmark of
excitable tissues such as myocardium is the ability to propagate electrical impulses. We utilized the method of
optical mapping to measure the electrical impulse propagation. The average conduction velocity recorded for the
stimulated constructs (14.4 4.1 cm=s) was significantly higher than that of the nonstimulated constructs
(8.6 2.3 cm=s, p¼ 0.003). The measured electrical propagation properties correlated to the contractile behavior
and the compositions of tissue constructs. Electrical stimulation during culture significantly improved amplitude
of contractions, tissue morphology, and connexin-43 expression compared to the nonsimulated controls. These
data provide evidence that electrical stimulation during bioreactor cultivation can improve electrical signal
propagation in engineered cardiac constructs.
Introduction
Cardiac tissue engineering has a potential to providefunctional tissue constructs for repair of myocardial in-
farction and congestive heart failure that currently affect close
to 12 million people in the United States alone.1 In an envi-
sioned scenario, the scar tissue resulting from pathological
remodeling after myocardial infarction can be replaced by a
synchronously contracting engineered cardiac patch. In con-
trast to skeletal tissues such as bone or cartilage where
patients can be asked to reduce the load bearing function of
these tissues for a period of time, some degree of function-
ality of an engineered cardiac patch is required immediately,
at the time of implantation. Importantly, engineered tissues
that are being developed for applications in regenerative
medicine can also find utility on a much shorter time scale
in studies of development, disease progression, and drug
screening, and in many other applications in biological and
medical research.
One paradigm of tissue engineering is that the reparative
cells can be induced to form functional tissue constructs
in vitro by cultivation on biomaterial scaffolds in bioreactors,
with these two components jointly providing the necessary
cues for cell differentiation and tissue assembly. A large num-
ber of scaffolds that are biodegradable and biocompatible are
available for cardiac tissue engineering,2–8 and significant
efforts in the field of stem cell biology are underway to find
clinically relevant source of cardiomyocytes.9–11 Most recen-
tly, an exciting possibility of induced pluripotency (iPS) cells
emerged, and it may be envisioned that iPS cells will provide
an autologous source of millions of cardiomyocytes required
for tissue engineering of human cardiac patches.12–16
However, it is the cultivation in bioreactors that enables us
to engineer contractile cardiac tissues in vitro and modulate
their functional properties. Our work is focused on devel-
oping bioreactor systems for cardiac tissue engineering using
neonatal rat cardiomyocytes as a model cell source, while we
anticipate that the same bioreactor systems will be translated
to clinically relevant sources of human cardiomyocytes.
We reported previously that cultivation of engineered
cardiac tissue in the presence of electrical field stimulation
(square pulses at the frequency of 1 Hz, signal amplitude of
5 V=cm, and signal duration of 2 ms) remarkably improved
cardiomyocyte function in engineered myocardium.17 The
surface of the stimulated tissue consisted of elongated cells ex-
pressing cardiac differentiation markers, sarcomeric a-actin,
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cardiac troponin I, and a and b myosin heavy chain. Re-
markably well-developed sarcomeres and gap junctions could
be seen by transmission electron microscopy.17
In native myocardium, cardiomyocytes form a three-
dimensional syncytium that enables propagation of electrical
signals across gap junctions to produce coordinated me-
chanical contractions that pump blood forward. Groups of
specialized cardiac myocytes (pace makers) generate electri-
cal impulses that are propagated through the ventricles to
drive periodic contractions of the heart. Excitation of each
cardiac myocyte is followed by the increase in the amount
of cytoplasmic calcium that in turn triggers mechanical con-
traction. Electrical propagation is therefore critical for the
function of the heart. Engineered constructs that cannot pro-
pagate electrical signals would have no utility for implan-
tation because they may result in conduction blocks or
generation of arrhythmia when implanted in the ventricles.
Thus, engineered cardiac tissues need to be evaluated for
impulse propagation.18 In the present study, we focused on
the characterization of electrical impulse propagation by
using optical mapping, and the method was used to deter-
mine the effects of electrical stimulation during cultivation
on functional properties in the resulting tissue constructs.
Our second objective was to investigate the effects of the
presence of nonmyocytes on engineered myocardium, as our
previous study focused exclusively on the identification and
characterization of cardiomyocytes.17 Cardiomyocytes ac-
count for only one third of all the cells found in the native
myocardium. However, due to their large size they occupy
90% of the volume and are critically responsible for con-
tractile function.19,20 The remaining two thirds of the cells
are fibroblasts and endothelial cells, with smaller numbers
of pericytes, smooth muscle cells, and macrophages.19,20 Fi-
broblasts secrete components of the extracellular matrix
and soluble factors, and transduce mechanical signals.20,21
Endothelial cells line the dense coronary vasculature and
regulate the autocrine and paracrine signaling important
in angiogenesis.22 Both cell types interact with cardiomyo-
cytes to coordinate tissue structure and function, and the
presence of both myocytes and nonmyocytes in the en-
gineered 3D cardiac tissue may be required for appropriate
function.23,24
Materials and Methods
Neonatal rat heart cells
Neonatal (1–2 days old) Sprague-Dawley rats were eutha-
nized according to the procedure approved by the Institute’s
Committee on Animal Care. The hearts were removed and
quartered, and the cells were isolated by an overnight treat-
ment with trypsin (48C, 6120 units=mL in Hank’s balanced
salt solution, HBSS) followed by serial collagenase digestion
(220 units=mL in HBSS) as described in previous work.25 The
supernatants from five collagenase digests of the tissues were
collected and centrifuged at 750 rpm (94 g) for 4 min, re-
suspended in culture medium, and preplated into T75 flasks
(BD Biosciences, Bedford, MA) for one 1 h interval to enrich
the cell suspension for cardiomyocytes. The culture medium
consisted of Dulbecco’s modified Eagle’s medium (Gibco,
Billings, MT) with 4.5 g=L glucose, 4 mM L-glutamine, 10%
certified fetal bovine serum (Gibco), 100 U=mL penicillin,
100 mg=mL streptomycin, and 10 mM 4-2-hydroxyethyl-1-pi-
perazineethanesulfonic acid buffer (HEPES; Gibco).
Collagen scaffold
The scaffolds were commercially available collagen
sponges, Ultrafoam (Davol). Dry collagen scaffold was
cross-sectioned using a sharp razor blade, sputter coated with
gold, and imaged in face and cross section using Hitachi
S3400N Variable Pressure Scanning Electron Microscope at the
Microscopy Imaging Laboratory, University of Toronto. For
imaging of the scaffold in the hydrated state, the scaffolds were
wetted in phosphate buffer saline and placed on the scanning
electron microscope stage with temperature set to 08C, and
the pressure was adjusted during imaging as required to pre-
vent formation of ice crystals and to obtain clear images.
Construct preparation
Ultrafoam collagen sponge scaffolds (8141.5 mm) were
prewetted with culture medium and placed into the 378C=5%
CO2 humidified incubator (Napco, Winchester, VA) for 1 hour
before inoculation. Cells (14106) were pelleted by centrifuga-
tion (1000 rpm, 10 min) and resuspended in Matrigel (70mL,
Becton-Dickinson) while working on ice to prevent premature
gelation as we described previously.2 Prewetted scaffolds were
gently blotted dry and placed in six-well plates (one=well),
and the Matrigel=cell suspension was delivered evenly to the
top surface of each scaffold using an automatic pipette. Ge-
lation was achieved within 15 min at 378C. Subsequently,
culture medium was added (4 mL=well), and the plates were
orbitally mixed (25 rpm) for 3 days. For reverse-transcription
and polymerase chain reaction (RT-PCR), the constructs were
prepared and stimulated in an identical manner except that the
thinner sponges (860.25 mm) were seeded with 1 million
cells; thus, the initial cell seeding density was identical.
Electrical stimulation
After 3 days of cultivation without electrical stimulation,
the constructs were transferred to a chamber consisting of
a 100 mm glass Petri dish fitted with two 1=8-inch-diameter
carbon rods (Ladd Research Industries, Williston, VT) placed
at a distance of 1 cm and connected to a commercial cardiac
stimulator (Nihon Kohden, Tokyo, Japan) via platinum wires
(Ladd Research Industries).25 Silicone tubing (Cole-Parmer,
Vernon Hills, IL) spacers were used to create six wells be-
tween the two electrodes, enabling the cultivation of six
constructs per dish (Fig. 1A). In one group (designated
‘‘stimulated’’), the constructs were stimulated with square
pulses, 2 ms in duration, supra-threshold amplitude of 5 V
(field strength of 5 V=cm), frequency of 1 Hz for the re-
mainder of cultivation (8 days). This stimulation voltage was
selected to induce synchronous construct contractions
(observable with optical microscope at 10 magnification).
Construct placed in an identical chamber but without elec-
trical stimulation served as control (designated ‘‘non-
stimulated’’). All chambers were orbitally mixed at 25 rpm.
Experiments were performed in a 378C=5% CO2 humidified
incubator. The evaluation of construct’s functional properties
and immunohistochemistry were performed at the end of
cultivation (8 days) as described below.
The excitation threshold of engineered cardiac constructs
was evaluated at the end of cultivation before optical map-
ping studies, by monitoring contractile activity upon elec-
trical stimulation at 10 magnification using a microscope
(Nikon Diaphot, Melville, NY).17 Each construct that was
evaluated was placed in a 100 mm Petri dish containing
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120 mL of Tyrode’s solution (140 mM NaCl, 5.4 mM KCl,
0.33 mM NaH2PO4, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM
HEPES, 5.5 mM D-glucose, pH 7.4) between two custom-
made gold electrodes connected to a cardiac stimulator
(Nihon Kohden). The temperature was maintained at 298C
using a heating tape (VWR International, Bridgeport, NJ)
attached to the bottom of the Petri dish. The stimuli (square
pulses, 2 ms duration) were applied at a rate of 1 Hz starting
at the amplitude of 1 V. The amplitude was increased in 0.1 V
increments until the entire construct was observed to beat
synchronously, a voltage defined as the excitation threshold.
To measure the amplitude of contractions, video-recorded
beating sequences (1–5 min in duration) were digitized at the
rate of 30 frames=s. The en-face area of each construct was
measured as function of time using image analysis (Scion
Image software, Scion, Frederick, MD). Plots of the construct
en-face area versus time were constructed and used to de-
termine the base-line area of the construct in the relaxed
state. Deviation of the construct area greater than *0.5%
from this baseline was considered to be the start of a con-
traction. The time at which the construct area returned to the
base-line value was considered to be the end of a contraction.
Duration of contraction was determined as the time period
between the start and end of the contraction. Amplitude of
contraction was expressed as fractional area change.
Optical mapping
For optical measurements, tissue constructs were trans-
ferred into a perfusion bath and superfused with Hanks
balanced salt solution having a composition of (mM): NaCl
137, KCl 5.4, KH2PO4 0.4, NaH2PO4 0.4, MgSO4 0.8, CaCl2
1.3, NaHCO3 4.2, HEPES 5.0, and glucose 5.1. The pH of the
solution was 7.4, and the temperature was kept constant
at 358C. Tissue constructs were stained with 5 mM solution
of fluorescent Vm-sensitive dye RH-237 (Molecular Probes,
Eugene, OR). Dye fluorescence was excited using a 200-W
Hg=Xe lamp at 530–585 nm, and emitted fluorescence was
measured at >650 nm using a microscopic mapping system
described previously.26,27 The system included a 1616 pho-
todiode array (Hamamatsu Corporation, Bridgewater, NJ) and
an inverted microscope (Axiovert 135TV; Zeiss, Jena, Ger-
many) with 5 and 10 objective lenses (Fluar, Zeiss, Jena,
Germany) allowing optical recordings at spatial resolutions of
110 and 55mm=diode. Tissue constructs were paced at 400-ms
cycle length using a bipolar electrode. Local activation times
were measured at the 50% level of action potential upstrokes.
Activation maps were constructed using linear interpolation
and triangulation algorithms between neighboring recording
locations. At each location, conduction velocity was calculated
using activation times at four neighboring sites. Conduction
velocity values from all sites were used to calculate the average
map conduction velocity.
Histology and immunostaining
At the end of cultivation the constructs were fixed in for-
malin for 24 h and paraffin embedded. The constructs were
sections such that the face-sectional area within the first
200 mm of the construct surface was revealed. The 5-mm
paraffin sections were deparaffinized and stained with he-
matoxylin and eosin, Mason’s trichrome, and smooth muscle
actin, at the Toronto General Hospital Pathology and His-
tology Laboratory, using standard protocols. Sections were
also immunostained in-house, with antibodies to monoclonal
rabbit anti-cardiac troponin I (DF 1:150; Chemicon, Teme-
cula, CA), monoclonal rat anti-vimentin (Cy3 conjugated,
DF 1:50; Sigma, St. Louis, MO), and polyclonal rabbit
anti-von Willebrand factor (DF 1:150; Chemicon) as we de-
scribed previously.28,29 Cell nuclei counterstaining with 40,6-
diamidino-2-phenylindole (DAPI) was done in the mounting
step using mounting medium containing DAPI (Vector La-
boratories, Burlingame, CA). Normal horse serum (10% in
phosphate buffered saline; Vector Laboratories) was used for
blocking prior to staining. Primary staining was done over-
night at 48C in a humidified chamber. Slides were incubated
with secondary antibody for 30 min at room temperature in a
humidified chamber using fluorescein isothiocyanate goat
anti-mouse (DF 1:64; Sigma) or fluorescein isothiocyanate
goat anti-rabbit (DF 1:200; Vector Laboratories) as required.
Optical microscopy images were taken using a Canon
PC1145 Powershot A620 Camera. Fluorescence imaging was
performed on a Leica DMIRE2 microscope, and images were
captured using Openlab 4.0.4 software.
RNA extraction
At the end of cultivation the constructs (n¼ 3 nonstimu-
lated, 3 stimulated) were transferred into 1.5 mL RNAse-
and DNAse-free tubes. The constructs were snap frozen by
placing the tubes directly into liquid nitrogen and immersing
them for 2 h. The constructs were then thawed at room
temperature for 10 min before addition of 0.5 mL of TRIzol
reagent (Invitrogen, Carlsbad, CA) to each tube for total
RNA extraction.
The samples were incubated in TRIzol at room tempera-
ture for 20 min, with occasional pipetting to facilitate cell
dissociation. 100 mL of chloroform was added to each tube,
followed by brief vortexing and centrifuging at 11000 rpm
(7440 g) for 15 min to separate the aqueous and organic
phases. The aqueous (RNA-containing) phase was then
transferred to a new tube, and the RNA was precipitated
by addition of 250mL of 2-propanol to each tube followed
by incubation at 808C for 1 h. RNA was pelleted by
centrifuging at 11,000 rpm (7440 g) for 10 min and then
washed by adding 500mL of 75% ethanol and briefly vor-
texing each tube. The RNA was again pelleted at 8800 rpm
(4762 g) for 5 min, and the supernatant discarded. The pellet,
containing total RNA, was then dissolved in 50 L of DNAse-
and RNAse-free distilled water and quantified using an ab-
sorption, single-beam biophotometer (Eppendorf, Hamburg,
Germany).
Reverse-transcription and polymerase chain reaction
Total RNA, 0.5mg, was reverse transcribed into first-strand
cDNA using the SuperScript III First Strand Synthesis System
(Invitrogen) according to the manufacturer’s protocol. For each
sample, a negative control in which the reverse transcriptase
enzyme was substituted with distilled water was included to
ensure that genomic DNA contamination was not present.
Polymerase chain reaction was used to amplify two genes of
interest: (1) connexin-43, an important gap junctional protein
involved in cell–cell coupling between myocytes, and (2) b-
actin, a highly conserved cytoskeletal protein, used here as a
housekeeping gene. Sequence-specific primers for these genes,
optimized for an annealing temperature of 528C, were as
follows:
OPTICAL MAPPING OF IMPULSE PROPAGATION IN ENGINEERED CARDIAC TISSUE 853
All PCR reactions were done in a reaction volume of 25mL,
and all reagents were obtained from Invitrogen. Two mL of
first-strand cDNA was amplified by PCR using the above
primers at a final concentration of 0.2 mM along with 0.2 mM
dNTPs, 1PCR Buffer (20 mM Tris-HCl at pH 8.4, 50 mM
KCl), 1.5 mM MgCl2, and 0.04 U=mL ‘‘Hot start’’ Platinum

Taq DNA Polymerase. Thermal cycling was performed in a
MultiGene II Thermocycler (Labnet International, Wood-
bridge, NJ) with the following parameters: an initial 2-min
denaturation at 948C, followed by 35 cycles of 948C for 30 s,
528C for 30 s, and 728C for 1 min were performed. A final
extension was performed at 728C for 1 min.
Gel electrophoresis and band densitometry
The PCR products, 6mL, were loaded in agarose gels (2%
w=v in TAE Buffer) with a 100 base pair ladder as a standard.
Gel electrophoresis was performed at 100 V for 30 min, and
visualization of gels was carried out by ethidium bromide
staining under UV light in a BioDoc-It Imaging System (UVP
Products, Upland, CA). Band densitometry was performed
using the Gel Analyzer option in ImageJ (National Institutes
of Health, version 1.36b) to generate lane profile plots. The
areas under these curves were measured and expressed as
percentages of the total area to produce a semi-quantitative
measure of mRNA expression. The resulting intensities for
the Cx43 bands and b-actin bands were plotted both as ab-
solute intensities as well as normalized and averaged to give
expression of Cx43 relative to b-actin.
Statistical analysis
The nonstimulated and stimulated groups were compared
using T-test with Sigma Stat 3.0. Normality and equality of
variance was tested for all data points. Differences were ac-
cepted to be statistically significant at p< 0.05.
Results
The Ultrafoam collagen scaffold exhibited an isotropic
macroporous structure with large interconnected pores. The
average pore diameter was 190mm, and the average wall
thickness was 8mm, as estimated from the dry-state images
(Fig. 1B). Pores as small as 1mm in diameter and fibers as
small as 1.5 mm in diameter were present within the network
of large pores. In the hydrated state, macroporous isotropic
pore structure was maintained (Fig. 1C).
Optical mapping was used to monitor impulse propaga-
tion after point stimulation and to measure the average con-
duction velocity over the whole mapping area. These studies
revealed fast and uniform propagation across the mapping
area in the constructs cultivated with electrical field stimu-
lation (Fig. 2A). In contrast, the nonstimulated constructs
exhibited nonuniform and slow signal propagation (Fig. 2B).
The average conduction velocity recorded for the stimulated
constructs (14.4 4.1 cm=s) was significantly higher than that
for the nonstimulated constructs (8.6 2.3 cm=s, p¼ 0.003)
(Fig. 3A). The maximal conduction velocity measured in the
stimulated constructs was 21.4 cm=s, which is similar to
the velocity measured in intact neonatal hearts,30,31 while the
smallest measured propagation velocity in the stimulated
group was 9.0 cm=s. In the nonstimulated group, we mea-
sured 13.0 and 2.6 cm=s as the maximum and minimum value
of the propagation velocity, respectively.
Consistent with our previous study, the excitation thresh-
old for electrical field stimulation (the minimum voltage
gradient necessary to induce synchronous macroscopic con-
tractions of a tissue construct) was slightly but not signifi-
cantly lower for stimulated constructs as compared to the
nonstimulated constructs (Fig. 3B). The amplitude of con-
struct contraction was evaluated in response to electrical
field stimulation at the voltage gradient 50% above the ex-
citation threshold, and calculated as the fractional change in
the construct area during the contraction cycle. The ampli-
tude of contractions was significantly higher for the stimu-
lated constructs compared to the constructs cultivated in the
absence of electrical field stimulation (Fig. 3C). In response
to the electrical field stimulation at 1 Hz, the duration of
contraction was comparable for the stimulated and non-
stimulated constructs (Fig. 3C), with the average duration
of contraction of 533 23 ms for stimulated constructs and
467 83 ms for nonstimulated constructs as measured from
the contraction profiles as those depicted in Figure 3C.
Mason’s trichrome staining (Fig. 4A, C) was used to deter-
mine the presence of cells within the scaffold pores. Because
the scaffold is comprised of denatured collagen, it stained
red in the trichrome staining (Fig. 4, asterisk). Cell deposited
collagen (blue) was present between the cells and on the pore
walls (Fig. 4A, C, arrows). Notably, in the stimulated group
the cells appeared significantly more elongated, preferen-
tially aligned in parallel to each other and present at higher
densities in the scaffold pores. In some regions, the prefer-
ential cell alignment appeared to be obstructed by isotropic
structure of the scaffold pores (Fig. 4C). In contrast, there
was no preferential cell orientation in the nonstimulated
group (Fig. 4A), the cell hypertrophy and elongation were
not apparent, and the numbers of cells filling the scaffold
pores appeared lower than in the stimulated group. Another
difference between the two groups was that the nonstimu-
lated constructs contained cells positive for smooth muscle
actin at face sections and the surfaces of the construct in
direct contact with culture medium (Fig. 4B). In contrast, the
staining for smooth muscle actin was completely absent at
face sections of stimulated constructs (Fig. 4D), and only oc-
casionally present in the surface layer that was in direct con-
tact with the culture medium (not shown).
Double staining for cardiac troponin I and vimentin
revealed the distributions and relative positions of cardiac
myocytes and nonmyocytes in the constructs. Consistent with
the heterogeneous cell population of the native heart iso-
late, both nonmyocytes and cardiomyocytes were identified
in engineered cardiac constructs (Supplemental Fig. S1A, C,
Gene Forward primer (50–30) Reverse primer (50–30)
Cx43 (110 bp) TTCATCATCTTCATGCTGGT ATCGCTTCTTCCCTTCAC
b-actin (165 bp) TAAAGACCTCTATGCCAACAC GATAGAGCCACCAATCCAC
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available online at www.liebertonline.com=ten). In the
nonstimulated group, cardiomyocytes (troponin I positive,
green, Supplemental Fig. S1A) were randomly dispersed
across the construct surface with no preferential orientation.
Besides being present on the scaffold surface, the non-
myocytes (vimentin positive, red, Supplemental Fig. S1A) in
the nonstimulated group exhibited no preferential direc-
tionality and were dispersed among the cardiomyocytes. In
the stimulated group, cardiac troponin I–positive cells were
found to exhibit preferential alignment (Supplemental
Fig. S1C, green), surrounded by nonmyocytes that were
located mainly on the construct surfaces (Supplemental
Fig. S1C, red). Positive staining for von Willebrand factor
was negligible in both groups, indicating the absence of
significant number of endothelial cells (Supplemental
Fig. S1B, D).
RT-PCR for Cx43 indicated significantly higher expression
of this gap junctional protein in the stimulated group than in
the nonstimulated group (Fig. 5A). The expression of house-
keeping gene, b-actin, was comparable in both groups (Fig. 5).
The absence of bands in negative controls, run without the
enzyme reverse transcriptase, indicated the absence of ge-
nomic contamination and specific amplification of Cx43
transcripts.
Discussion
A hallmark of excitable tissues such as myocardium is the
ability to propagate electrical impulses, a property that di-
rectly correlates with the tissue functionality. Thus, our goal
was to evaluate the velocity of impulse propagation in car-
diac tissues cultivated in electrical stimulation bioreactors,
using optical mapping. Previously, the velocity of impulse
propagation in the ventricles of 2-day-old Sprague Dawley
rats was measured to be 25.4 cm=s using a linear electrode
array,30 while the velocity in the heart ventricles of 10-day-
old rats was measured to be 27 cm=s.31 The stimulated
constructs in this study exhibited the average propagation
velocity of *55% of that in the native heart, while the
highest measured average propagation velocity was *80%
of that measured in the native heart. In contrast, the average
propagation velocity in the nonstimulated group was only
*32% of that found in the native heart. The observed im-
pulse propagation velocity was comparable to that repor-
ted previously for neonatal rat cardiomyocytes cultivated on
the anisotropic poly(glycolic acid) scaffolds.18 In that previ-
ous study, the velocity of impulse propagation in the longi-
tudinal direction (i.e., parallel to the cell and scaffold fibre
long axis) was *15 cm=s at 6 days of cultivation (which is
in line with the results reported for our stimulated group
cultivated for total of 8 days, Fig. 3A) and increased to
*20 cm=s after 10 days of cultivation. In the transverse di-
rection, the propagation velocity of *10 cm=s was measured
over the entire cultivation period,18 consistent with the values
measured in the present study for the nonstimulated group
(Fig. 3B).
The enhanced propagation velocity in the stimulated
group was most likely a result of improved cellular elonga-
tion and parallel orientation in response to the electrical
field gradient, which were observed both in this study
(Fig. 4C) and in our previous studies,25 as well as improved
cardiomyocyte coupling suggested by the increase in Cx43
FIG. 1. Electrical field stimulation cultivation system. (A)
Set-up for electrical field stimulation consisting of a 100 mm
Petri dish fitted with 1=8-inch carbon rods connected to a
commercially available cardiac stimulator via platinum
wires. (B) Cross section of collagen scaffold in dry state.
(C) Cross section of the collagen scaffold in the hydrate
state representing scaffold topography that would be expe-
rienced by the cells. Color images available online at www
.liebertonline.com=ten.
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expression (Fig. 5). Cx43 is predominant in the gap junctions
of the ventricular cardiomyocytes in the native heart. In our
previous studies, using immunostaining for Cx43 and mor-
phometric analysis of TEM images, we demonstrated that
the frequency of gap junctions in the stimulated group was
comparable to that of the native heart, while in the non-
stimulated group the frequency was significantly lower than
that of the native heart. It is possible that upon implantation
and maturation of the cardiac constructs in vivo, the propa-
gation velocity would enhance further. For example, Zim-
mermann et al.32 reported that cardiac constructs based on
neonatal rat cardiomyocytes maintained for 4 weeks in the
adult rat myocardium had maximum conduction velocity of
55 16 cm=s longitudinally and 16 7 cm=s transversally,
comparable to the conduction velocity in the noninfarcted
adult rat myocardium (69 6 cm=s longitudinally and 19
5 cm=s transversally).
Porous collagen scaffold has an isotropic pore structure as
illustrated by scanning electron microscopy of the scaffold
in dry as well as hydrated state (Fig. 1B, C). The field stim-
ulation and excitation–contraction coupling guide parallel
orientation and rearrangement of cardiomyocytes in the
stimulated group that is opposed by the isotropic pores that
force the elongating cells to ‘‘turn-corners’’ at the pore walls
(Fig. 4C). To a certain extent, cells are capable of remodeling
the isotropic pore structure via action of cellular proteases
and traction forces; however, perfect alignment is hard to
achieve with isotropic scaffolds. Several recent studies of
cardiomyocyte cultivations on anisotropic scaffolds clearly
indicated the importance of scaffold topography in guiding
FIG. 2. Optical mapping of
activation spread in en-
gineered cardiac tissues.
(A) Isochronal activation map
(top) and selected optical
recordings of action poten-
tial upstrokes (bottom) in a
stimulated tissue sample.
(B) Activation map and opti-
cal recordings in a non-
stimulated control. Red circles
on optical traces depict acti-
vation times. The average
conduction velocity was 20.4
and 5.4 cm=s in (A) and (B),
respectively. Color images
available online at www
.liebertonline.com=ten.
856 RADISIC ET AL.
FIG. 3. Excitability and contractile properties of engineered
cardiac tissues. (A) Conduction velocity as determined by
optical mapping. (B) Excitation threshold in response to
electrical field stimulation. (C) Construct area change
during paced contractions for engineered cardiac tissue
cultivated with electrical field stimulation and non-
stimulated controls. *Significantly higher than non-
stimulated control. In (A) and (B) data are represented
as average SE for n¼ 9 samples in the stimulated
group and n¼ 7 samples in the nonstimulated group.
In (C) data are represented as average SE with n¼ 4
samples in the stimulated group and n¼ 6 samples in the
nonstimulated group.
FIG. 4. Histological characteriza-
tion of engineered cardiac tissue.
(A, B) Nonstimulated controls.
(C, D) Stimulated samples. (A, C)
Mason’s trichrome staining. Col-
lagen scaffold stains bright red (*),
cells appear dark pink, nuclei ap-
pear dark blue, and cell-deposited
collagen appears light blue (arrow).
(B, D) Immunostaining for smooth
muscle actin. Positive cells appear
brown (arrow). Scale bar: 50mm.
Color images available online at
www.liebertonline.com=ten.
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functional properties of engineered cardiac structures.4,18 We
expect that cultivation of neonatal rat cardiomyocytes on
scaffolds with oriented (anisotropic) pores or fibers in the
presence of electrical field stimulation would further enhance
the propagation velocity and contractile properties of the en-
gineered cardiac tissue.
Because cardiac fibroblasts can rapidly overgrow cardio-
myocytes in monolayer cultures, the cell suspension used for
monolayer studies is routinely enriched for cardiomyocytes
by preplating. By analogy, early cardiac tissue engineering
studies involved the use of cell populations enriched for
cardiomyocytes by preplating,33–37 and some studies dem-
onstrated that the velocity of impulse propagation increased
with an increase in the fraction of cardiomyocytes in the cell
preparation.34 Zimmermann, Eschenhagen, and coworkers23,37
recognized the importance of the presence of multiple cell
types for the in vitro cultivation of heart tissue in their culti-
vation system with cyclic stretch. Previously, we characterized
only cardiomyocytes in the stimulated and nonstimulated
constructs,25 but in this study we also evaluated the presence
of nonmyocytes.
In our hands, the composition of neonatal rat heart cell
suspension after one 1 h preplating step was 64 5% cardi-
omyocytes (cardiac troponin I–positive cells) and 34 16%
fibroblasts (prolyl-4-hydroxylase–positive cells),29 while after
two 1 h preplating steps the isolate was enriched for cardi-
omyocytes (81 14% cardiomyocytes vs. 16 3% fibro-
blasts). The fraction of other cell types remained low (e.g.,
3 3% endothelial cells).38 During cultivation, the fibroblasts
persisted in the constructs but did not overgrow cardio-
myocytes (Supplemental Fig. S1), possibly due to the mi-
croarchitecture of the scaffold pores.39 Because endothelial
cells were mostly absent in these constructs (Supplemental
Fig. S1B, D), coculture or scaffold prevascularization in vitro
may be required. Alternatively, scaffolds with immobilized
angiogenic factors may be utilized40 to promote rapid vas-
cularization in vivo. Interestingly, in the present study there
were no smooth muscle actin–positive cells in the face sec-
tions of stimulated constructs, while remarkably higher num-
bers were present in the nonstimulated constructs (Fig. 4).
Because smooth muscle cells account for only *3% of the
native heart cell isolate after one preplating,23 the smooth
muscle actin–positive cells in the nonstimulated constructs
may be myofibroblasts. The myofibroblasts exhibit elevated
secretion of extracellular matrix proteins; they are implicated
in scarring upon myocardial infarction41 and the decrease in
propagation velocity when present in critical numbers (e.g.,
more than 7 myofibroblasts per 100 cardiomyocytes).42
Electrical field stimulation bioreactor, such as the one used
here, may prove to be a useful tool in engineering cardiac
constructs based on human stem=progenitor cell sources.
The bioreactor we used is simple to construct and operate,
thus enabling easy translation into other research laborato-
ries and ultimately clinical practice. Electrical field stimula-
tion is provided by a pair of parallel carbon electrodes (Fig.
1A), positioned 1 cm apart within a glass chamber and con-
nected to a commercially available stimulator or a custom-
made pulse generator=amplifier circuit. In our previous
studies we have tested a number of electrode materials (ti-
tanium, titanium nitride, and stainless steel) in addition
to carbon.43 We found that carbon was indeed an optimal
material for this application due to high resistance to polar-
ization and Faradaic reactions, high efficiency of charge
transfer to electrolyte (and hence to the tissue construct), and
FIG. 5. Expression of gap
junctional protein connexin-
43. (A) Gels showing
connexin-43 and b-actin ex-
pression. Lane 1, ladder;
lanes 2–4, three independent
nonstimulated samples sub-
jected to RT-PCR without
the reverse transcriptase
enzyme; lanes 5–7, three in-
dependent stimulated sam-
ples subjected to RT-PCR
without the reverse transcrip-
tase enzyme; lanes 8–10, three
independent nonstimulated
samples subjected to RT-PCR
with the reverse transcriptase
enzyme; lanes 11–13, three
independent stimulated
samples subjected to RT-PCR
with the reverse transcriptase
enzyme. (B) Densitometric
analysis of bands represented
in (A). (C) Relative expres-
sion of connexin-43 in compa-
rison to b-actin (connexin-43=
b-actin band intensity
average SD).
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low impedance modulus across a large frequency range
(102 to 106 Hz). Further, although the impedance of carbon
electrodes decreased with age when low frequencies (e.g.,
1 Hz) were used, its resistance to Faradaic reactions remained
unchanged, indicating that the same setup can be re-used for
numerous experiments. The resistance measured in the bio-
reactors with carbon rods spaced 1 cm apart was 20O and
10O for 8- and 4-cm-long electrodes, respectively.44 Total
charge injected with a single 5 V=cm pulse of 2 ms duration
in a setup consisting of a 60 mm Petri dish with 20 mL of
phosphate buffered saline was measured to be 2.3104 C.43
The collagen scaffold used in this study was a commer-
cially available hemostat, Ultrafoam, which is water insolu-
ble, and formed from the partial HCl salt of purified bovine
dermal (corium) collagen as a sponge with interconnected
pores. Because it has already gained FDA approval as a
hemostat, this scaffold may indeed be a suitable material for
engineering of a clinically relevant cardiac patch. For cell
seeding, we used rapid inoculation of the cells at high den-
sity with a hydrogel (Matrigel).2 Because Matrigel is derived
from the basement membrane of a mouse sarcoma, it is not
suitable for preparation of clinically relevant constructs.
Currently, we have complementary efforts underway to re-
place Matrigel by biodegradable hydrogels of controllable
composition based on chitosan45 or hyaluronic acid.46
Approaches to improve the current bioreactor involve
development of second-generation bioreactors that incorpo-
rate mechanical stimulation37 or culture medium17 flow along
with electrical field stimulation. One approach to providing
mechanical stimulation in such a bioreactor would include
pulsatile culture medium flow, where a culture medium
pulse would be applied between the electrical pulses. To en-
sure that the constructs are not moving during an experi-
ment, they can be fixed by pinning into a thin layer of
poly(dimethylsiloxane) cast on the bottom of the chamber.43
In summary, we demonstrated here that the engineered
cardiac tissue cultivated in the presence of electrical field
stimulation exhibits impulse propagation comparable to that
of the neonatal rat ventricles. The tissues were comprised of
multiple cell types, mostly cardiomyocytes and fibroblasts;
however, no overgrowth of fibroblasts was observed. In the
stimulated group, the fibroblasts were confined to the sur-
face layer of the construct in the direct contact with the
culture medium. Endothelial cells were largely absent in both
groups, while smooth muscle–positive cells, most likely
myofibroblasts, were more numerous in the nonstimulated
group than in the stimulated group.
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